Hi Jeff

Thanks for replying. I'm already on ADT & ARSI (Orgovyx and Nubequa). Treatment plan, as presented, is stay on ADT & ARSI for 3-4 months then add 30 +/- sessions of EBRT while continuing ADT & ARSI indefinitely. I'm looking for a study, everyone keeps referring to, that states adding EBRT, to a patient with low volume mCSPC already under treatment with ADT & ARSI, is more beneficial than ADT & ARSI alone and how much so. It's the how much so part that will guide my decision as to radiation or not. EBRT is to prostate only, not any metastasizes.

And...I found them. It's the STAMPEDE trial and the HORRAD trial.